GO
Loading...

Merck CEO: Significant Need for New Blockbuster Drugs

Wednesday, 23 Jan 2013 | 5:30 AM ET

Ken Frazier, CEO of Merck, tells CNBC about the challenges of finding new blockbuster drugs and how any change to Medicare funding must have a sustainable benefit.